Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia.

MLA

Fobare, Sydney, et al. “Molecular, Clinical, and Prognostic Implications of PTPN11 Mutations in Acute Myeloid Leukemia.” Blood Advances, vol. 6, no. 5, Mar. 2022, pp. 1371–80. EBSCOhost, https://doi.org/10.1182/bloodadvances.2021006242.

APA

Fobare, S., Kohlschmidt, J., Ozer, H. G., Mrózek, K., Nicolet, D., Mims, A. S., Garzon, R., Blachly, J. S., Orwick, S., Carroll, A. J., Stone, R. M., Wang, E. S., Kolitz, J. E., Powell, B. L., Oakes, C. C., Eisfeld, A.-K., Hertlein, E., & Byrd, J. C. (2022). Molecular, clinical, and prognostic implications of PTPN11 mutations in acute myeloid leukemia. Blood Advances, 6(5), 1371–1380. https://doi.org/10.1182/bloodadvances.2021006242

Chicago

Fobare, Sydney, Jessica Kohlschmidt, Hatice Gulcin Ozer, Krzysztof Mrózek, Deedra Nicolet, Alice S Mims, Ramiro Garzon, et al. 2022. “Molecular, Clinical, and Prognostic Implications of PTPN11 Mutations in Acute Myeloid Leukemia.” Blood Advances 6 (5): 1371–80. doi:10.1182/bloodadvances.2021006242.